(Q31027945)

28 June 2017

1 reference

title

Clinical-magnetic resonance imaging correlations in multiple sclerosis (English)

1 reference

28 June 2017

0 references

1

Robert Zivadinov

1 reference

28 June 2017

Thomas P Leist

2

1 reference

28 June 2017

publication date

1 January 2005

1 reference

28 June 2017

published in

Journal of Neuroimaging

1 reference

28 June 2017

volume

15

1 reference

28 June 2017

issue

4 Suppl

1 reference

28 June 2017

page(s)

10S-21S

1 reference

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Immunopathogenesis of the multiple sclerosis lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Role of MRI in multiple sclerosis I: inflammation and lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Imaging of multiple sclerosis: role in neurotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Spinal cord imaging in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Patterns of blood-brain barrier breakdown in inflammatory demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Magnetization transfer imaging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Correlations of brain MRI parameters to disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Improved correlation between scores on the expanded disability status scale and cerebral lesion load in relapsing-remitting multiple sclerosis. Results of the application of new imaging methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Primary progressive multiple sclerosis: a 5-year clinical and MR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Contrast-enhanced MRI lesions during treatment with interferonbeta-1b predict increase in T1 black hole volume in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Magnetic resonance spectroscopy in the monitoring of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Central nervous system atrophy and clinical status in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Role of MRI in multiple sclerosis II: brain and spinal cord atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

A semiautomated measure of whole-brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Measurement of spinal cord atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

One year follow up study of primary and transitional progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1051228405283291

21 January 2018

Identifiers

DOI

10.1177/1051228405283291

1 reference

28 June 2017

1 reference